Featured News & Highlights
Who Should Own Your Clinical Study URL? A Practical Guide for Sponsors
It sounds like a small administrative detail—but in practice, URL ownership shapes how your trial operates from day one through closeout. It can influence everything from study startup timelines to change control processes, migration costs, and long-term data governance.
Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) Announce Biostatistics Partnership to Advance Research in Friedreich’s Ataxia
TORONTO and PHILADELPHIA — February 27, 2026 —Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA)…
Everest Clinical Research to Expand Asia Pacific Operations with New Biometrics Team in the Philippines
Expansion will strengthen global biometrics delivery and support continued growth across the globe TORONTO — February 3,…
Everest Clinical Research Welcomes Amy Nguyen as Chief Commercial Officer to Drive Continued Global Growth
TORONTO, December 17, 2025 — Everest Clinical Research, a global, full-service CRO, announces the appointment of Amy…
Everest Strengthens Global Biometrics Capabilities with Expansion in Poland
TORONTO – November 24, 2025 – Everest Clinical Research— a data-driven and quality-focused global CRO — is…
Everest Enhances Regulatory Strategy and Capabilities with the Appointment of Kevin Barber as Senior Vice President of Global Regulatory Strategy and Submissions
TORONTO — July 30, 2025 — Everest Clinical Research, a quality and data-driven global CRO, announces the appointment…
Everest Clinical Research Enables Faster and Higher Quality Data Insights for Trial Sponsors with Medidata Clinical Data Studio
TORONTO –June 5, 2025 – Medidata, a Dassault Systèmes brand, today announced that Everest Clinical Research, a global full-service
Everest Clinical Research Announces Key Leadership Appointments to Drive Continued Growth
TORONTO – February 13, 2025 – Everest Clinical Research Corporation (Everest), a global full-service Contract Research Organization (CRO),…
Everest Announces Acquisition of August Research
TORONTO —November 7, 2023—Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise…